Found: 22
Select item for more details and to access through your institution.
Colesevelam Plus Rosuvastatin 5 mg/Day Versus Rosuvastatin 10 mg/Day Alone on Markers of Insulin Resistance in Patients with Hypercholesterolemia and Impaired Fasting Glucose.
- Published in:
- Metabolic Syndrome & Related Disorders, 2013, v. 11, n. 3, p. 152, doi. 10.1089/met.2012.0103
- By:
- Publication type:
- Article
Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in women.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2008, v. 24, n. 3, p. 223, doi. 10.1002/dmrr.784
- By:
- Publication type:
- Article
Lipid Target Achievement Among Patients With Very High and High Cardiovascular Risk in a Lipid Clinic.
- Published in:
- Angiology, 2015, v. 66, n. 4, p. 346, doi. 10.1177/0003319714535073
- By:
- Publication type:
- Article
Gender Differences in the Epidemiology, Clinical Presentation, Prevention, and Prognosis of Acute Coronary Syndromes.
- Published in:
- Angiology, 2013, v. 64, n. 1, p. 5, doi. 10.1177/0003319712446188
- By:
- Publication type:
- Article
Obstructive Sleep Apnea and Cardiovascular Risk: Is Metabolic Syndrome the Link?
- Published in:
- Angiology, 2012, v. 63, n. 8, p. 569, doi. 10.1177/0003319711436077
- By:
- Publication type:
- Article
Statins and mortality: the untold story.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 5, p. 938, doi. 10.1111/bcp.13202
- By:
- Publication type:
- Article
Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome.
- Published in:
- Journal of the Renin-Angiotensin-Aldosterone System, 2007, v. 8, n. 4, p. 181, doi. 10.3317/jraas.2007.027
- By:
- Publication type:
- Article
The association between Type D personality and the metabolic syndrome: a cross-sectional study in a University-based outpatient lipid clinic.
- Published in:
- BMC Research Notes, 2011, v. 4, n. 1, p. 105, doi. 10.1186/1756-0500-4-105
- By:
- Publication type:
- Article
The impact of the metabolic syndrome on health-related quality of life: a cross-sectional study in Greece.
- Published in:
- European Journal of Cardiovascular Nursing, 2012, v. 11, n. 3, p. 297, doi. 10.1016/j.ejcnurse.2011.02.004
- By:
- Publication type:
- Article
Lipoprotein (a) as a treatment target for cardiovascular disease prevention and related therapeutic strategies: a critical overview.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 5, p. 739, doi. 10.1093/eurjpc/zwab052
- By:
- Publication type:
- Article
Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 1, p. 11, doi. 10.2165/13168600-000000000-00000
- By:
- Publication type:
- Article
Fenofibrate and the kidney: an overview.
- Published in:
- European Journal of Clinical Investigation, 2013, v. 43, n. 5, p. 522, doi. 10.1111/eci.12068
- By:
- Publication type:
- Article
Rosuvastatin Increases α-1 Microglobulin Urinary Excretion in Patients With Primary Dyslipidemia.
- Published in:
- Journal of Clinical Pharmacology, 2006, v. 46, n. 11, p. 1337, doi. 10.1177/0091270006292629
- By:
- Publication type:
- Article
The Effect of Rosuvastatin on Low-Density Lipoprotein Subfractions in Patients With Impaired Fasting Glucose.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2015, v. 20, n. 3, p. 276, doi. 10.1177/1074248414549419
- By:
- Publication type:
- Article
Effect of Atorvastatin Monotherapy and Low-Dose Atorvastatin/Ezetimibe Combination on Fasting and Postprandial Triglycerides in Combined Hyperlipidemia.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Efficacy and Safety of Ezetimibe Plus Orlistat or Rimonabant in Statin-Intolerant Nondiabetic Overweight/Obese Patients With Dyslipidemia.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2009, v. 14, n. 4, p. 274, doi. 10.1177/1074248409343935
- By:
- Publication type:
- Article
Dose-dependent Effect of Rosuvastatin Treatment on HDL-subfraction Phenotype in Patients With Primary Hyperlipidemia.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2009, v. 14, n. 1, p. 5, doi. 10.1177/1074248408331031
- By:
- Publication type:
- Article
An Overview of the Extra-Lipid Effects of Rosuvastatin.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2008, v. 13, n. 3, p. 157, doi. 10.1177/1074248408318628
- By:
- Publication type:
- Article
Dose-Dependent Effect of Rosuvastatin Treatment on Urinary Protein Excretion.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2007, v. 12, n. 4, p. 292, doi. 10.1177/1074248407306676
- By:
- Publication type:
- Article
Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 308, n. 10, p. 1024, doi. 10.1001/2012.jama.11374
- By:
- Publication type:
- Article
Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases.
- Published in:
- 2014
- By:
- Publication type:
- journal article